Back to Agenda
Defining an Inclusive Clinical Trials Approach in Europe
Session Chair(s)
Ambily Banerjee, PhD
Senior Director/Head of Diversity in Clinical Trials
Johnson and Johnson Innovative Medicine, United Kingdom
This forum will address industry challenges in the recruitment and retention of underserved populations in clinical research, and explores how regulators, physicians, sponsors and others can work together to develop solutions to tackle health equity.
Learning Objective : Identify a proposal for addressing underrepresentation of underserved populations in Europe; Describe regulatory and industry perspectives in addressing recruitment and retention challenges for multi-regional clinical trials; Discuss best practices that can help shape inclusivity of clinical trials across borders.
Speaker(s)
The EU Perspective and the Role of ACT EU
Ana Zanoletty Perez
European Medicines Agency, Netherlands
Head of Clinical Trials Transformation Workstream
Evolving FDA Perspective Based on Learningd from DAP Submissions on What Diversity Looks Like
M. Khair ElZarrad, PhD, MPH
FDA, United States
Director, Office of Medical Policy, CDER
Industry Perspective of Community Engagement in Europe: A Case Study
Monique Adams, PhD, MS
Sanofi, United States
Executive Director, Global Head Diversity and Inclusion in Clinical Trials
CT Network One-Pager v2
Nicholas Brooke, MBA
PFMD, Belgium
Executive Director, Patient Focused Medicines Development (PFMD)
Have an account?